Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer.

SEQTOR trial shows comparable PFS for STZ/5-FU followed by everolimus and the reverse sequence in advanced pancreatic NETs.

By targeting three key growth pathways at once, researchers eliminated pancreatic tumors in multiple mouse models and ...

Pancreatic cancer accounts for about 3 percent of all cancers, but it causes around 7 percent of all cancer deaths. In 2022, the World Health Organiza.

Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic ...

Scientists have created a new antibody treatment that helps the immune system recognize and attack pancreatic cancer. Pancreatic cancer cells use a sugary "disguise" to trick the immune system into ...

Add Yahoo as a preferred source to see more of our stories on Google. While every cancer is daunting, pancreatic cancer is particularly alarming because of its notoriously low cure rate. There’s no ...

A novel four-protein biomarker blood panel promotes early pancreatic cancer detection, identifying 91.9% of cancer cases and surpassing standard tests.